Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

866 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multicenter, phase II trial of triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for highly emetogenic chemotherapy in breast cancer (PATROL-II).
Suzuki K, Yokokawa T, Kawaguchi T, Takada S, Tamaki S, Kawasaki Y, Yamaguchi T, Koizumi K, Matsumoto T, Sakata Y, Arakawa Y, Ayuhara H, Hosonaga M, Yamaguchi M, Tsuji D. Suzuki K, et al. Among authors: tamaki s. Sci Rep. 2024 Nov 16;14(1):28271. doi: 10.1038/s41598-024-79781-6. Sci Rep. 2024. PMID: 39550497 Free PMC article. Clinical Trial.
Genetic Risk Factors Associated With Antiemetic Efficacy of Palonosetron, Aprepitant, and Dexamethasone in Japanese Breast Cancer Patients Treated With Anthracycline-based Chemotherapy.
Yokoyama S, Tamaru S, Tamaki S, Nakanishi D, Mori A, Yamakawa T, Ao T, Sakata Y, Mizuno T, Iwamoto T, Watanabe K, Simomura M, Kawakami K, Konishi N, Kageyama S, Ohtani S, Yamada T, Ban S, Ooi K. Yokoyama S, et al. Among authors: tamaki s. Clin Breast Cancer. 2018 Apr;18(2):e157-e165. doi: 10.1016/j.clbc.2017.05.013. Epub 2017 Jun 29. Clin Breast Cancer. 2018. PMID: 28735677
Chemotherapy-induced neutropenia as a prognostic factor in patients with extensive-stage small cell lung cancer.
Miyagi T, Tsuji D, Kawasakai Y, Ishikawa H, Tanaka R, Nakao M, Nakagaki S, Hayashi T, Ayuhara H, Harada T, Tamaki S, Maeda A, Ohashi Y, Arakawa Y, Fujita Y, Yamamoto K, Miyamoto Y, Yano T, Itoh K. Miyagi T, et al. Among authors: tamaki s. Eur J Clin Pharmacol. 2023 Mar;79(3):407-414. doi: 10.1007/s00228-023-03451-1. Epub 2023 Jan 16. Eur J Clin Pharmacol. 2023. PMID: 36645467
Pharmacogenomic study of gemcitabine efficacy in patients with metastatic pancreatic cancer: A multicenter, prospective, observational cohort study (GENESECT study).
Hatori M, Tsuji D, Suzuki K, Yokokawa T, Kawakami K, Moriyama R, Osada-Tsuchiya M, Otake A, Nakao M, Yano T, Arakawa Y, Matsuo K, Ohashi Y, Sakata Y, Kogure Y, Tamaki S, Wada A, Taki Y, Sasahira N, Ishii H, Yamaguchi M, Itoh K. Hatori M, et al. Among authors: tamaki s. Cancer. 2024 Sep 1;130(17):2988-2999. doi: 10.1002/cncr.35343. Epub 2024 Apr 29. Cancer. 2024. PMID: 38682652
866 results